Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
July 20, 2022
CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic
Read More
August 3, 2022
Mountain Climbing: CAMP4 Aims to Scale the Heights of Disease
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
May 31, 2018
Press Releases
CAMP4 Therapeutics Launches with Platform to Discover Effective Treatment Approaches for Every Disease, Announces $30 Million Series A Financing
«
1
2
Media Contact:
PR@camp4tx.com
Top
